374 related articles for article (PubMed ID: 19129465)
1. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
Chiluiza D; Krishna S; Schumacher VA; Schlöndorff J
J Biol Chem; 2013 Jun; 288(25):18407-20. PubMed ID: 23645677
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
4. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
[TBL] [Abstract][Full Text] [Related]
5. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
6. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.
Koitabashi N; Aiba T; Hesketh GG; Rowell J; Zhang M; Takimoto E; Tomaselli GF; Kass DA
J Mol Cell Cardiol; 2010 Apr; 48(4):713-24. PubMed ID: 19961855
[TBL] [Abstract][Full Text] [Related]
8. Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway.
Xia S; Liu Y; Li X; Thilo F; Tepel M
Cell Physiol Biochem; 2016; 38(2):659-69. PubMed ID: 26849622
[TBL] [Abstract][Full Text] [Related]
9. SNF8, a member of the ESCRT-II complex, interacts with TRPC6 and enhances its channel activity.
Carrasquillo R; Tian D; Krishna S; Pollak MR; Greka A; Schlöndorff J
BMC Cell Biol; 2012 Nov; 13():33. PubMed ID: 23171048
[TBL] [Abstract][Full Text] [Related]
10. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation-dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis.
Kanda S; Harita Y; Shibagaki Y; Sekine T; Igarashi T; Inoue T; Hattori S
Mol Biol Cell; 2011 Jun; 22(11):1824-35. PubMed ID: 21471003
[TBL] [Abstract][Full Text] [Related]
12. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic signaling evoked by tumor necrosis factor in podocytes.
Abkhezr M; Kim EY; Roshanravan H; Nikolos F; Thomas C; Hagmann H; Benzing T; Dryer SE
Am J Physiol Renal Physiol; 2015 Jul; 309(2):F98-108. PubMed ID: 26017975
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
16. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.
Kim EY; Anderson M; Dryer SE
Am J Physiol Renal Physiol; 2012 Feb; 302(3):F298-307. PubMed ID: 22031853
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
18. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients.
Zhu B; Chen N; Wang ZH; Pan XX; Ren H; Zhang W; Wang WM
Mutat Res; 2009 May; 664(1-2):84-90. PubMed ID: 19124028
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane insertases and
Talbot BE; Vandorpe DH; Stotter BR; Alper SL; Schlondorff JS
J Biol Chem; 2019 Aug; 294(34):12655-12669. PubMed ID: 31266804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
